Tags : MVP

MVP and Daiichi Signs Exclusive Distribution and License Agreement for

Shots: Medical Developments International (MVP) to receive up to $32.5M (AUD $45.8M) as total deal value plus $15M upfront and additional sales-based milestones payments MVP will fund the regulatory process of Penthrox in China and both companies will jointly collaborate with Japan’s service provider, EPS International Holdings for its approval. MVP will hold the drug […]Read More